<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <bill>
    <billNumber>917</billNumber>
    <createDate>2021-03-24T04:42:14Z</createDate>
    <updateDate>2022-03-04T01:12:11Z</updateDate>
    <originChamber>Senate</originChamber>
    <billType>S</billType>
    <introducedDate>2021-03-23</introducedDate>
    <congress>117</congress>
    <recordedVotes/>
    <committees>
      <billCommittees>
        <item>
          <systemCode>sshr00</systemCode>
          <name>Health, Education, Labor, and Pensions Committee</name>
          <chamber>Senate</chamber>
          <type>Standing</type>
          <subcommittees/>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2021-03-23T20:01:57Z</date>
            </item>
          </activities>
        </item>
      </billCommittees>
    </committees>
    <committeeReports/>
    <relatedBills/>
    <actions>
      <item>
        <actionDate>2021-03-23</actionDate>
        <committees>
          <item>
            <systemCode>sshr00</systemCode>
            <name>Health, Education, Labor, and Pensions Committee</name>
          </item>
        </committees>
        <links/>
        <sourceSystem>
          <code>0</code>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2021-03-23</actionDate>
        <links/>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees/>
      </item>
      <actionTypeCounts>
        <referredToCommittee>1</referredToCommittee>
        <introducedInSenate>1</introducedInSenate>
      </actionTypeCounts>
      <actionByCounts>
        <senate>2</senate>
      </actionByCounts>
    </actions>
    <sponsors>
      <item>
        <bioguideId>K000367</bioguideId>
        <fullName>Sen. Klobuchar, Amy [D-MN]</fullName>
        <firstName>Amy</firstName>
        <middleName/>
        <lastName>Klobuchar</lastName>
        <party>D</party>
        <state>MN</state>
        <identifiers>
          <lisID>1826</lisID>
          <bioguideId>K000367</bioguideId>
          <gpoId>8249</gpoId>
        </identifiers>
        <byRequestType/>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>L000577</bioguideId>
        <fullName>Sen. Lee, Mike [R-UT]</fullName>
        <firstName>Mike</firstName>
        <middleName/>
        <lastName>Lee</lastName>
        <party>R</party>
        <state>UT</state>
        <identifiers>
          <lisID>2080</lisID>
          <bioguideId>L000577</bioguideId>
          <gpoId>8303</gpoId>
        </identifiers>
        <sponsorshipDate>2021-03-23</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <sponsorshipWithdrawnDate/>
      </item>
      <item>
        <bioguideId>D000563</bioguideId>
        <fullName>Sen. Durbin, Richard J. [D-IL]</fullName>
        <firstName>Richard</firstName>
        <middleName>J.</middleName>
        <lastName>Durbin</lastName>
        <party>D</party>
        <state>IL</state>
        <identifiers>
          <lisID>326</lisID>
          <bioguideId>D000563</bioguideId>
          <gpoId>8326</gpoId>
        </identifiers>
        <sponsorshipDate>2021-03-23</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <sponsorshipWithdrawnDate/>
      </item>
      <item>
        <bioguideId>G000386</bioguideId>
        <fullName>Sen. Grassley, Chuck [R-IA]</fullName>
        <firstName>Charles</firstName>
        <middleName>E.</middleName>
        <lastName>Grassley</lastName>
        <party>R</party>
        <state>IA</state>
        <identifiers>
          <lisID>457</lisID>
          <bioguideId>G000386</bioguideId>
          <gpoId>8316</gpoId>
        </identifiers>
        <sponsorshipDate>2021-03-23</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <sponsorshipWithdrawnDate/>
      </item>
    </cosponsors>
    <cboCostEstimates/>
    <laws/>
    <notes/>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Congressional oversight</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
          <item>
            <name>Trade restrictions</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <actionDate>2021-03-23</actionDate>
          <actionDesc>Introduced in Senate</actionDesc>
          <lastSummaryUpdateDate>2021-07-06T22:03:34Z</lastSummaryUpdateDate>
          <text>
            <![CDATA[ <p><b>Short on Competition Act</b></p> <p>This bill requires the Food and Drug Administration (FDA) to provide temporary authorization to import certain prescription drugs facing shortages or in a marginally competitive drug market. </p> <p> Specifically, the FDA shall authorize importation of an eligible drug that is lifesaving, life-sustaining, or intended to treat or prevent a debilitating condition. To be eligible, a drug must (1) be facing a shortage, (2) require a prescription, (3) have received market authorization in certain foreign countries, and (4) have the same active ingredient as the drug for which there is a shortage in the United States. The drug's manufacturer must also seek FDA approval for the drug as a generic drug.</p> <p>The import authorization shall be for three years or until the shortage no longer applies, whichever occurs first. Importation shall begin within 60 days of the FDA receiving an application that meets all of the applicable requirements. The FDA may deny importation of a drug for reasons related to safety or effectiveness.</p> <p>Drugs in marginally competitive markets must be treated as being in a shortage for the purposes of this bill and for the purposes of expedited inspections and review. A drug is in a marginally competitive market if (1) there are fewer than five holders of approved applications for commercially available brand-name or generic versions of the drug, (2) the drug has been approved for at least 10 years, and (3) the patents on the drug's active ingredients have expired.</p>]]>
          </text>
          <updateDate>2021-03-23T04:00:00Z</updateDate>
          <name>Introduced in Senate</name>
        </item>
      </billSummaries>
    </summaries>
    <title>Short on Competition Act</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <parentTitleType/>
        <title>Short on Competition Act</title>
        <chamberCode/>
        <chamberName/>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <parentTitleType>Short Title</parentTitleType>
        <title>Short on Competition Act</title>
        <chamberCode/>
        <chamberName/>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <parentTitleType/>
        <title>A bill to allow for expedited approval of generic prescription drugs and temporary importation of prescription drugs in the case of marginally competitive drug markets and drug shortages.</title>
        <chamberCode/>
        <chamberName/>
      </item>
    </titles>
    <amendments/>
    <textVersions>
      <item>
        <type>Introduced in Senate</type>
        <date>2021-03-23T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-117s917is/xml/BILLS-117s917is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2021-03-23</actionDate>
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
      <links/>
    </latestAction>
    <calendarNumbers/>
    <version>1.0.0</version>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
